Hypothalamic endoplasmic reticulum stress drives pubertal precocity due to early-onset obesity in female rodents
Abstract
Early-onset obesity, especially in girls, is frequently associated with advanced puberty; a phenomenon bound to increased risk of long-term complications. Hypothalamic endoplasmic reticulum (ER) stress has been implicated in the pathophysiology of obesity and its comorbidities. However, its contribution to pubertal disorders associated with obesity remains unexplored. We report herein that central ER stress drives obesity-induced precocious female puberty. Hypothalamic expression of key ER stress markers was blunted during normal pubertal transition and altered in female rats with early-onset obesity and advanced puberty, which displayed increased levels of p-PERK and p-eIF2α, and reduced ATF6α content. Central stimulation of hypothalamic ER stress with Thapsigargin in prepuberal lean female rats mimicked advanced puberty onset caused by obesity, without changes in body weight. This phenomenon seemingly involves a circuit including the hypothalamic arcuate nucleus (ARC), since obesity-induced precocious puberty was largely prevented by alleviation of ER stress via virogenetic overexpression of the ER chaperone, GRP78, in the ARC, but not in the paraventricular nucleus, in female rats. In addition, expression analyses of ER stress markers in mouse Kiss1 neurons isolated from juvenile and pubertal female mice revealed increased expression of Perk and Ire1α mRNAs in Kiss1 ARC neurons in early-overfed mice at the juvenile stage, while Xbp1s/u expression ratio was significantly increased during juvenile–pubertal transition in overweighed mice. Collectively, our data uncover a relevant role of hypothalamic ER stress in the control of female puberty and the pathogenesis of obesity-induced pubertal alterations.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (16)
Elvira Rodríguez-Vázquez
Instituto Maimónides de Investigación Biomédica de Córdoba
Álvaro Aranda-Torrecillas
Instituto Maimónides de Investigación Biomédica de Córdoba
Manuel Jiménez-Puyer
Instituto Maimónides de Investigación Biomédica de Córdoba
Oscar Freire-Agulleiro
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III
María J. Sánchez-Tapia
Instituto Maimónides de Investigación Biomédica de Córdoba
Miguel Ruiz-Cruz
Instituto Maimónides de Investigación Biomédica de Córdoba
Violeta Heras
Instituto Maimónides de Investigación Biomédica de Córdoba
María López-Sancho
Instituto Maimónides de Investigación Biomédica de Córdoba
Luisina Ongaro
Department of Pharmacology and Therapeutics, McGill University
Cecilia Perdices-López
Instituto Maimónides de Investigación Biomédica de Córdoba
Daniel J. Bernard
Rafael Pineda
Instituto Maimónides de Investigación Biomédica de Córdoba
Francisco Gaytan
Instituto Maimónides de Investigación Biomédica de Córdoba
Miguel López
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III
Juan M. Castellano
Instituto Maimónides de Investigación Biomédica de Córdoba
Manuel Tena-Sempere
Instituto Maimónides de Investigación Biomédica de Córdoba